Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern Ohio

American Journal of Clinical Pathology

Volumn 132, Issue 5, 2009, Pages 668-677

  Delorme, Thierry ^a   Rose, Stacy ^a   Senita, Julie ^a   Callahan, Cynthia ^b   Nasr, Payman ^a  

^a KENT STATE UNIVERSITY   (United States)

^b Ashtabula County Medical Center   (United States)

Author keywords

Community acquired; Epidemiology; Hospital acquired; Methicillin resistance; MRSA; Staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CEFALOTIN; CEFAZOLIN; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; COMMUNITY; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL EXAMINATION; NURSING HOME PATIENT; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; UNITED STATES; AGE DISTRIBUTION; DISEASE PREDISPOSITION; MIDDLE AGED;

ADOLESCENT; AGE DISTRIBUTION; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, MICROBIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OHIO; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 70449719244     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPQ46ZPQXVHHNC     Document Type: Article

References (38)

1. Krziwanek K, Luger C, Sammer B, et al. MRSA in Austria: an overview. Clin Microbiol Infect. 2008;14:250-259.
2. Feng Y, Chen C, Su L, et al. Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev. 2008;32:23-37. (Pubitemid 350293912)
3. Jevons MP. "Celbenin"-resistant staphylococci. Br Med J. 1961;1:124-125.
4. Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961;14:385-393.
5. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992;13:582-586.
6. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1997;24(suppl 1):S74-S79.
7. Moreillon P. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Clin Microbiol Infect. 2008;14:32-41.
8. Zlomek Hedden A. Community-associated MRSA. Adv Nurse Pract. 2007;15:59-64.
9. Fang H, Hedin G, Li G, et al. Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005. Clin Microbiol Infect. 2008;14:370-376.
10. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community acquired MRSA. Lancet. 2002;359:1819-1827. (Pubitemid 34607058)
11. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care - associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984. (Pubitemid 37505530)
12. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-1444.
13. Vandenesch F, Naimi T, Enright MC, et al. Community acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-984. (Pubitemid 36944519)
14. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41(suppl 4):S269-S272.
15. Bureau of the Census, US Department of Commerce. State & County QuickFacts. 2006. http://quickfacts.census.gov/qfd/states/39/39007.html. Accessed March 2, 2009.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; document M100-S16. Wayne, PA: CLSI; 2006.
17. Centers for Disease Control and Prevention. Invasive MRSA. 2007. http://www.cdc.gov/ncidod/dhqp/ar-mrsa-Invasive-FS.html. Accessed March 2, 2009.
18. Lee TC, Carrick MM, Scott BG, et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg. 2007;194:809-813.
19. Patel M, Waites KB, Hoesley CJ, et al. Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies. J Hosp Infect. 2008;68:208-213.
20. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest. 2007;87:3-9. (Pubitemid 44973648)
21. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-182.
22. Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired meticillin resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005;5:275-286. (Pubitemid 40602247)
23. Furuya EY, Cook HA, Lee MH, et al. Community-associated methicillin-resistant Staphylococcus aureus prevalence: how common is it? a methodological comparison of prevalence ascertainment. Am J Infect Control. 2007;35:359-366.
24. Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med. 2006;119:943-951.
25. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286:1201-1205. (Pubitemid 33015549)
26. Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol. 2007;56:1-16.
27. David MZ, Crawford SE, Boyle-Vavra S, et al. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis. 2006;12:631-636.
28. Hamour SMA, O'Bichere A, Peters JL, et al. Patient perceptions of MRSA. Ann R Coll Surg Engl. 2003;85:123-125.
29. Trigg D, Timmons S, Pynegar C. An audit of healthcare workers' knowledge of methicillin resistant Staphylococcus aureus (MRSA) against current infection control standards. Br J Infect Control. 2008;9:30-33.
30. Lugg GR, Ahmed HA. Nurses' perceptions of meticillin-resistant Staphylococcus aureus: impacts on practice. Br J Infect Control. 2008;9:8-14.
31. Girard R, Amazian K, Fabry J. Better compliance and best tolerance in relation to a well-conducted introduction to rub-in hand disinfection. J Hosp Infect. 2001;47:131-137. (Pubitemid 32181727)
32. Parker LJ. Importance of handwashing in the prevention of cross infection. Br J Nurs. 2000;8:1-8.
33. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital wide program to improve compliance with hand hygiene. Lancet. 2000;356:1307-1312. (Pubitemid 30831854)
34. Gould D. Systematic observation of hand decontamination. Nurs Stand. 2004;18:39-44.
35. Luszczynska A, Gunson KSE. Predictors of asking medical personnel about handwashing: the moderating role of patients' age and MRSA infection status. Patient Educ Couns. 2007;68:79-85. (Pubitemid 47126794)
36. Henderson DK. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Am J Infect Control. 2006;34(5 suppl 1):S46-S54, S64-S73.
37. Raboud J, Saskin R, Wong K, et al. Patterns of handwashing behaviour and visits to patients on a general medical ward of healthcare workers. Infect Control Hosp Epidemiol. 2004;25:198-202. (Pubitemid 38339623)
38. van de Mortel T, Bourke R, McLoughlin J, et al. Gender influences handwashing rates in the critical care unit. Am J Infect Control. 2001;29:395-399. (Pubitemid 34014546)